## 3 Results
\begin{table}
\begin{tabular}{l c c} \hline \multicolumn{3}{c}{**\% Weight Loss (r)**} \\ \hline \multicolumn{3}{c}{**Total (n = 39)**} & **Women (n = 11)** & **Men (n = 28)** \\ \hline Age (y) & 0.092 (\(p\) = 0.576) & 0.050 (\(p\) = 0.884) & 0.130 (\(p\) = 0.511) \\ BMI (kg/m\({}^{2}\)) & 0.292 (\(p\) = 0.072) & 0.400 (\(p\) = 0.223) & 0.222 (\(p\) = 0.256) \\ Body fat (\%) & 0.118 (\(p\) = 0.473) & 0.127 (\(p\) = 0.709) & 0.191 (\(p\) = 0.332) \\ Lean mass (kg) & 0.108 (\(p\) = 0.514) & 0.618 (\(p\) = 0.043) & 0.079 (\(p\) = 0.690) \\ Lean mass index (kg/m\({}^{2}\)) & 0.158 (\(p\) = 0.337) & 0.618 (\(p\) = 0.043) & 0.147 (\(p\) = 0.456) \\ High BMI-high \% body fat pattern & 0.164 (\(p\) = 0.318) & 0.200 (\(p\) = 0.555) & 0.185 (\(p\) = 0.346) \\ High BMI-high lean tissue pattern & 0.166 (\(p\) = 0.313) & 0.618 (\(p\) = 0.043) & 0.149 (\(p\) = 0.450) \\ Glucose (mg/dL) & \(-0.270\) (\(p\) = 0.128) & \(-0.714\) (\(p\) = 0.047) & \(-0.154\) (\(p\) = 0.462) \\ Glycated hemoglobin, HbA1c (\%) & \(-0.145\) (\(p\) = 0.428) & \(-0.143\) (\(p\) = 0.736) & \(-0.139\) (\(p\) = 0.518) \\ Total-cholesterol (mg/dL) & \(-0.150\) (\(p\) = 0.377) & 0.231 (\(p\) = 0.521) & \(-0.218\) (\(p\) = 0.227) \\ HDL-cholesterol (mg/dL) & \(-0.026\) (\(p\) = 0.877) & \(-0.588\) (\(p\) = 0.074) & 0.199 (\(p\) = 0.321) \\ Triglycerides (mg/dL) & \(-0.410\) (\(p\) = 0.012) & \(-0.067\) (\(p\) = 0.855) & \(-0.601\) (\(p\) = 0.001) \\ \hline \end{tabular}
\end{table} 
Table 4: Spearman correlation coefficients between % weight loss and several variables in the CDSS intervention group for the total sample and separately for men and women. \begin{table}
\begin{tabular}{l c c c c c c} \hline \multicolumn{3}{c}{**Men (n = 28)**} & \multicolumn{3}{c}{**Women (n = 11)**} \\ \multicolumn{3}{c}{**Baseline**} & **Follow-Up** & \(p\)**-Value** & **Baseline** & **Follow-Up** & \(p\)**-Value** \\ \hline Body weight (kg) & \(87.9\pm 14.9\) & \(83.3\pm 13.9\) & \(<\)0.001 & \(114.6\pm 25.4\) & \(109.2\pm 21.4\) & \(<\)0.001 \\ BMI (kg/m\({}^{2}\)) & 31.9 (28.3-36.2) & 30.3 (26.7-34.6) & \(<\)0.001 & \(36.2\) (28.8-40.1) & \(35.1\) (29.4-36.5) & 0.021 \\ Total body fat (\%) & \(46.9\pm 9.8\) & \(43.2\pm 9.7\) & \(<\)0.001 & \(39.9\pm 13.8\) & \(37.3\pm 11.5\) & \(<\)0.001 \\ Lean tissue (kg) & \(22.41\) (21.5-26.1) & \(23.5\) (19.9-25.9) & \(1.07\) & \(354.0\) (29.1-41.6) & \(32.8\) (28.0-38.5) & 0.109 \\ Lean mass index (kg/m\({}^{2}\)) & \(8.83\) (80.3-9.22) & \(8.80\) (7.6-9.16) & \(0.178\) & \(108.3\) (9.92-11.67) & \(9.9\) (9.0) (90.1-11.76) & 0.091 \\ Glucose (mg/dL) \(\dagger\) & \(89\) (80–93) & \(87\) (85–97) & \(0.010\) & \(75\) (92–98) & \(88\) (85–96) & 0.220 \\ Glyated hemoglobin, HbA1c (\%) & \(5.25\pm 0.44\) & \(5.06\pm 0.46\) & \(0.151\) & \(5.31\pm 0.83\) & \(4.83\pm 0.29\) & 0.077 \\ Total-cholesterol (mg/dL) & \(182\pm 38\) & \(164\pm 39\) & \(<\)0.001 & \(19\pm 61\) & \(164.2\pm 38.9\) & 0.069 \\ LDL-cholesterol (mg/dL) & \(111\) (91–119) & \(109\) (35–121) & \(0.237\) & \(109\) (87–138) & \(107\) (99–130) & 0.109 \\ HDL-cholesterol (mg/dL) & \(55\) (45–67) & \(50\) (40–52) & \(0.343\) & \(59\) (45–68) & \(57\) (41–65) & 0.705 \\ Triglycerides (mg/dL) & \(137\) (110–144) & \(130\) (108–138) & \(0.018\) & \(135\) (116–189) & \(140\) (107–194) & 0.109 \\ \hline \end{tabular}
\end{table} 
Table 2: Differences pre- and post-CDSS intervention stratified by sex. \begin{table}
\begin{tabular}{l c c} \hline \multicolumn{3}{c}{**Pattern 1:**} & **Pattern 2:** \\ \multicolumn{3}{c}{**High BMI-High \% Body Fat**} & **High BMI–High Lean Tissue** \\ \hline BMI at baseline (kg/m\({}^{2}\)) & **0.873** & **0.473** \\ Lean mass at baseline (kg) & 0.014 & **0.997** \\ Body fat at baseline (\%) & **0.975** & \(-0.195\) \\ \hline \% variance explained & 60.4\% & 38.4 \% \\ Total variance explained 98.9\% & \\ \hline \end{tabular}
\end{table} 
Table 3: Factor loadings using principal component analysis for the identification of body weight patterns in the CDSS intervention group.